MYOPEPDYS (VESLETEPLIRSEN) INJECTION
DEAD

Serial Number

98370905

Owner

SAREPTA THERAPEUTICS, INC.

Attorney

Maury M. Tepper, III

Filing Date

Jan 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MYOPEPDYS (VESLETEPLIRSEN) INJECTION Trademark

Serial Number: 98370905

MYOPEPDYS (VESLETEPLIRSEN) INJECTION is a trademark filed by SAREPTA THERAPEUTICS, INC. on January 23, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

SAREPTA THERAPEUTICS, INC. (109 trademarks)

215 FIRST STREET, SUITE 7
CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

January 23, 2024

Registration Date

Not Registered

Published for Opposition

October 1, 2024

Goods & Services

Medical services; providing health information

Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Medical training and teaching

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 30, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 30, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 23, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 23, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 23, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 23, 2024 CNEA
ASSIGNED TO EXAMINER
Aug 19, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 28, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2024 NWOS
NEW APPLICATION ENTERED
Jan 23, 2024 NWAP